Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Invested Capital (2016 - 2026)

Veracyte's Invested Capital history spans 14 years, with the latest figure at $1.3 billion for Q4 2025.

  • On a quarterly basis, Invested Capital rose 9.89% to $1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 9.89% increase, with the full-year FY2025 number at $1.3 billion, up 9.89% from a year prior.
  • Invested Capital hit $1.3 billion in Q4 2025 for Veracyte, up from $1.3 billion in the prior quarter.
  • Over the last five years, Invested Capital for VCYT hit a ceiling of $1.3 billion in Q4 2025 and a floor of $971.2 million in Q2 2021.
  • Historically, Invested Capital has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2021.
  • Biggest five-year swings in Invested Capital: skyrocketed 327.93% in 2021 and later decreased 5.21% in 2022.
  • Tracing VCYT's Invested Capital over 5 years: stood at $1.1 billion in 2021, then dropped by 1.83% to $1.1 billion in 2022, then dropped by 2.75% to $1.0 billion in 2023, then rose by 13.97% to $1.2 billion in 2024, then rose by 9.89% to $1.3 billion in 2025.
  • Business Quant data shows Invested Capital for VCYT at $1.3 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.2 billion in Q2 2025.